Fri, 18th Dec 2015 11:15
LONDON (Alliance News) - Physiomics PLC, which aims to streamline the discovery and development of drugs, on Friday said it has raised GBP250,000 by selling new shares.
The company issued 1.00 billion new shares at 0.025 pence each. The stock was trading down 6.3% at 0.0328p on Friday.
The funds raised from the placing will be used for working capital purposes, Physiomics said.
By Samuel Agini; samagini@alliancenews.com; @samuelagini
Copyright 2015 Alliance News Limited. All Rights Reserved.
Physiomics PLC - Milton Park, England-based data science company, focused on new therapeutics and personalised medicine solutions - Warns several larg...
(Sharecast News) - Therapeutics and medicine-focussed mathematical modelling and data science company Physiomics said in an update on Friday that, des...
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.
Physiomics PLC - mathematical modelling company that supports oncology drug development - Receives a "substantial" new contract by an existing "large ...
(Sharecast News) - Mathematical modelling and data science company Physiomics has been awarded "a substantial new contract" by an existing large pharm...
Physiomics (PYC)